The FAAs Diabetes or Hyperglycemia on Oral Medication Status Report form does the trick
In a 12-week study, participants receiving 1 mg daily lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg in the placebo group
Theo Haradis has talked about luteolin, and his NeuroProtect, I think, is another great product that is more for the central nervous system, because it's so good at absorbing that it kind of bypasses the gut and goes right into the brain
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, OFarrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept